HYDERABAD MANUFACTURING FACILITY
Time to shed fear and think positive? 5 mid-cap stocks from different sectors with upside potential of up to 33%
Mid-cap stocks tend to move more than large-caps. And that works both ways. They rise faster when the market is rising, and fall harder when it is falling. Keep that in mind as the market’s mood changes for the better because oil prices are dropping and the macro worries responsible for the long sell-off are starting to go away.
Rare earth magnet scheme: Coal India, IRP seek no sops; other contenders include ReNew, Prozeal
The scheme will run for seven years from the date of award, including a two-year gestation period for setting up an integrated manufacturing facility, and five years for incentive disbursement on the sale of REPM. These magnets are among the most powerful in the world and are widely used in electric vehicles, wind turbines, high-end electronics, aerospace and defence systems.
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28% in 1 year, according to analysts
Despite the upbeat mood in the market, remember one thing: Valuations are still not cheap. Even after everything the market has been through, prices are not at a level you could call a bargain. So this is not a signal to rush in. It is a signal to stop treating every development as a threat, and to start weighing the good against the bad with a clear head, rather than a frightened one.
These mid-caps have ‘strong buy’ & ‘buy’ recos and upside potential of up to 28%, according to analysts
Global markets on Wednesday celebrated the outcome of the US mid-term election as well as a sharp drop in oil prices. Oil prices, which at the end of last week were at about $118 to the barrel, are now under $95. The hope clearly is that Democrat control of both chambers of the US Congress will pressure the Trump administration to pursue a diplomatic end to the conflict with Iran in the Gulf.
Lenskart outlines roadmap for 25% Ebitda margin, says growth will take priority
In its shareholders' letter for the July-September quarter, the company said its strategy centred on controlling the entire value chain, from manufacturing frames and lenses to selling products directly to consumers, allowing it to retain margins otherwise distributed among suppliers and retailers.
Premji Invest goes big on strategic output & tech
Premji Invest and Singularity AMC are likely to lead a $30-40 million round in Sanlayan at a valuation of about $200 million, according to the people. Separately, Premji Invest is in advanced talks to lead Hical’s first institutional funding round of $30-40 million, alongside TVS Capital.
- Go To Page 1
For investors with a 3- to 5-year horizon: 5 mid-cap stocks from different sectors with upside potential of more than 19%
A development worth noting is that there was net FII buying in five of the last six trading sessions. But it is still tentative, and cannot be declared as a reversal of the selling trend of the past few months. While indications are that they are favouring large-cap stocks, there are bargains to be had in the mid-cap space for the discerning investor.
His grandfather died of pancreatic cancer: This Hyderabad startup founder is using AI to develop a personalised cancer vaccines
Hyderabad-based biotech startup PopVax, founded by Soham Sankaran, is developing AI-powered personalised cancer vaccines using mRNA technology. Inspired partly by his family's experience with pancreatic cancer, he aims to help the immune system identify and attack cancer cells using treatments designed around individual patients' tumour genetics.
5 stocks with consistent score improvement and upside potential of up to 34% in 1 year, according to analysts
The recent uptick in the indices should not fool you. The market’s troubles have not gone away. So, be cautious, but don’t treat the whole market as one block. Some parts are worse off, some are holding up better, and some are simply carrying on as before. A falling market tends to paint them all with the same brush.
Sun Pharma ordered to halt eye drug production at Assam plant over quality lapses: Report
Indian regulators have ordered Sun Pharmaceutical Industries to stop manufacturing ophthalmic products at the Assam facility. This decision followed the discovery of failures in the company's quality management system. A joint inspection cited lapses that affected drug safety and quality, leading to a recall of several eye-drop brands. Significant adverse cases have raised concerns regarding product contamination, prompting further investigation.
These large-, mid- and small-cap stocks can give more than 20% return in 1 year, according to analysts
Here’s one thing that is worth clarifying, because it is in the headlines. Large global technology companies have been announcing heavy spending on AI, and there has been some correction in those stocks because of it. It is natural to worry that this will spill over into the Indian market. It most likely will not.
For investors with ability to look past the current bearish narrative: 5 large-cap stocks with upside potential of up to 34%
One stock not falling on bad news does not mean the worst is over for the whole market. It may mean only that the bears have, for now, taken out of that one stock all that they wanted to. The broader pressure can still come back. So this is a small positive, and it should be considered just that, and nothing more.
These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analysts
When a market is as jittery as it is right now, poor numbers are treated harshly. A new-age company in the business of buying and selling used cars reported numbers that fell short, and the street punished the stock severely. But it is not just the clear misses. Anything that is well-owned and presents disappointing numbers is seeing double-digit cuts.
5 stocks with consistent score improvement and upside potential of up to 30% in 1 year, according to analysts
When the profit a company is expected to earn gets marked down, the price the market will pay for its stock has to come down too. That has not quite happened, which is why valuations are still high in many parts of the market. So, don’t assume all the damage is already done just because the market has had a few bad days.
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption
Dr Reddy’s Laboratories has expanded its generic semaglutide portfolio with Obeda Pro and Obeda Plus after supplies of its original Obeda injection were halted in July for technical evaluation. The new brands are manufactured by Hetero Labs, while distributors say the company may discontinue Obeda injectable supplies. Dr Reddy’s denies a replacement strategy.
These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analysts
The last few weeks have made one thing clear. Oil prices, US bond yields, corporate earnings, and the state of the world – all point the same way. So, the market is more likely to stay in this jumpy and uncertain mood for quite some time. But then there is something called history, and it provides some interesting lessons.
State of Joy strengthens India footprint with 4,000+ retail touchpoints and plans for exclusive brand outlets
State of Joy has launched Anatom, an innovative footwear collection that prioritizes comfort and practicality. This collection features Anatom School Shoes, specifically designed to meet the daily requirements of children. With an emphasis on meticulous engineering, these shoes are ideal for all-day wear. As part of its growth strategy, State of Joy plans to broaden its retail footprint across India, targeting both Tier 1 and Tier 2 markets.
How Byju’s parent funded Aakash rights issue; Zetwerk IPO fully subscribed
Happy Dussehra! Byju’s parent used money repaid by Great Learning to back Aakash’s rights issue. This and more in today’s ETtech Morning Dispatch.
Skyroot eyes funding boost; MDR deferment cheers D2C brands
Happy Thursday! Skyroot is eyeing a big funding round as it gears up to scale rocket production. This and more in today’s ETtech Morning Dispatch.
Novo Holdings, GIC, Axight look to back AIG Hospitals; Founders aim to pare 10-12% stake at Rs 24,000 cr valuation
Novo Holdings and GIC are discussing investing Rs 2,000-2,500 crore in AIG Hospitals based in Hyderabad. The investment reflects a growing interest among private equity firms in Indian healthcare. Founders of AIG Hospitals, Duvvur Nageshwar Reddy and Penmetsa Venkata Subbaraju, are planning a stake sale. AIG Hospitals has plans for a new facility in Visakhapatnam and aims to grow significantly.
Want an early signal on the economy and stocks this festive season? Watch 19 stocks, and what their managements say in the next 20 days
There is a set of companies that sees the shape of the economy before economists do. They know when a household decides to spend or hold back; to buy better things or cheaper ones. This festive season, what these companies sell, and what they say about it afterwards, will tell you more about where consumption is headed than any official number. Watch them closely. Check out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focusing on five key components – earnings, fundamentals, relative valuation, risk, and price momentum – to generate standardised scores. SR+ Reports is a complimentary offering to ETPrime members.
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%
A piece of advice for those who still have the stomach to invest in the current volatile market. Don’t take any price action as the gospel truth; look beyond the index movements. And, finally, be both cautious and selective in your stock picks.
5 stocks with consistent score improvement and upside potential of up to 30% in 1 year, according to analysts
Keep a close watch on updates from FMCG companies, the cement sector, from real estate companies, especially about the commercial segment of those focused on South India. What they say will provide an idea of how things are panning out on the ground.
Aragen Life Sciences begins operations at high-potency platform in Hyderabad
Aragen Life Sciences has initiated operations at its new high-potency manufacturing platform in Hyderabad. The facility, measuring 15,000 square feet, can produce 500-600 kg of active pharmaceutical ingredients annually. It aims to streamline the transition of highly potent molecules from discovery to commercial supply. The company has invested over Rs 1,000 crore in capital expenditures over three years.
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 20%
In times like these, the market will have its green and red days. What matters, however, is not the colour of a single day, but the things underneath it: The central bank, the fund flows, and, above all, corporate earnings. Watch those, stay patient, and forget the daily noise.
Defence stocks: Time to change strategy in a bearish market? An ecosystem with down and upside potential of -39% to plus 37%
The current fall is both at the level of the indices and the broader market. And when the selling is this broad, almost every sector is affected. But they do not all feel it equally, and it is worth knowing why every sector behaves differently at different points of time. Stock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, fundamentals, relative valuation, risk, and price momentum – to generate standardised scores. The simple average of the above-mentioned five component ratings is normally distributed to reach an average score.
When every number is a risk, the watchlist matters more than the buy list: 5 mid-cap stocks with upside potential of up to 26%
There are times when the market forgives a weak quarter, and there are times when it does not. We are now in the second kind of market. The cushion that softened bad news a few months ago has gone, and the coming Q2 results will carry burdens that the earlier ones did not. So, before looking at any stock, remember this: The odds of a sharp fall because of any disappointment are higher now than they have been in a while.
Azad Engineering shares jump 10% as company expands GE Vernova's manufacturing footprint
Azad Engineering shares jumped after the company inaugurated two dedicated lean manufacturing facilities for GE Vernova’s Gas Power business in Hyderabad, expanding its dedicated manufacturing footprint for the global energy major to three facilities.
ET Startup Awards 2026: Armatrix targets 10-12 pilots, commercial deployment of snake-like robotic arms in 2028
Armatrix won the Best on Campus category at The Economic Times Startup Awards 2026 for its 3-5 metre long snake-like robotic arms designed to navigate narrow and hazardous industrial spaces where conventional robots and workers struggle to operate. It won for its clearly defined use cases.
Load More
